News
Dr Ryuji Sakakibara, Department of Neurology Chiba University 1–8–1 Inohana, Chuo-ku, Chiba 260–8670 Japan. Telephone 0081 43 226 2129; fax 0081 43 226 2160; emailsakaki{at}med.m.chiba-u.ac.jp ...
Department of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei 10051, Taiwan Dr Sung-Tsang Hsieh, Department of Neurology, National Taiwan University Hospital, 7 ...
Objective Multiple sclerosis (MS) is associated with chronic symptoms, including muscle stiffness, spasms, pain and insomnia. Here we report the results of the Multiple Sclerosis and Extract of ...
A peer-reviewed neurology, neurosurgery and psychiatry journal publishing the latest research and reviews on the entire genre of neurological sciences.
College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA Avi Ashkenazi, MD, Department of Neurology, Thomas Jefferson University, 111 South 11th ...
Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review ...
There have been many articles highlighting differences and similarities between complex regional pain syndrome (CRPS) and functional neurological disorders (FND) but until now the discussions have ...
OBJECTIVES To clarify the nosological relation among Miller Fisher syndrome (MFS), Guillain-Barré syndrome (GBS) with ophthalmoplegia, Bickerstaff's brain stem encephalitis (BBE), and acute ...
Background Oral anticoagulation (OAC) effectively reduces stroke risk in patients with atrial fibrillation (AF), but its use ...
1 Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands 2 Department of Neuropathology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands Correspondence to Dr John C.
Background Benign multiple sclerosis (MS), characterised by minimal disability despite long disease duration, remains poorly understood in terms of its determinants and prognostic implications. While ...
Background Smoking is a significant risk factor for neurological disorders, yet its global impact on these conditions remains underexplored. Methods Using Global Burden of Diseases 2021 data, we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results